Spots Global Cancer Trial Database for stage ii adult soft tissue sarcoma
Every month we try and update this database with for stage ii adult soft tissue sarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Radiation Therapy Plus Doxorubicin in Treating Patients With Resectable Primary or Recurrent Retroperitoneal Soft Tissue Sarcoma | NCT00004123 | Sarcoma | Doxorubicin hyd... Conventional su... Intraoperative ... Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma | NCT00822848 | Sarcoma | epirubicin hydr... ifosfamide sorafenib tosyl... immunoenzyme te... immunohistochem... laboratory biom... adjuvant therap... neoadjuvant the... therapeutic con... hypofractionate... | 15 Years - 120 Years | OHSU Knight Cancer Institute | |
| Studying Genes in Samples From Younger Patients With Desmoplastic Small Round Cell Tumor Registered on COG-D9902 or COG-ABTR01B1 | NCT01430637 | Sarcoma | DNA analysis RNA analysis gene expression... mutation analys... nucleic acid se... polymerase chai... laboratory biom... pharmacogenomic... | - 50 Years | Children's Oncology Group | |
| Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma | NCT00002492 | Sarcoma | cisplatin doxorubicin hyd... isolated limb p... conventional su... brachytherapy radiation thera... | 18 Years - 120 Years | University of Miami | |
| Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis | NCT00091351 | Sarcoma | conventional su... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma | NCT00004261 | Breast Cancer Cervical Cancer Head and Neck C... Prostate Cancer Sarcoma | EF5 flow cytometry fluorescent ant... immunohistochem... biopsy | 18 Years - 120 Years | University Health Network, Toronto | |
| Bevacizumab in Treating Patients With Angiosarcoma | NCT00288015 | Sarcoma | Bevacizumab | 18 Years - | Northwestern University | |
| Cryosurgery in Treating Patients With Soft Tissue Sarcoma | NCT00002863 | Sarcoma | chemotherapy conventional su... cryosurgery | - | University of Southern California | |
| Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma | NCT00023738 | Sarcoma | filgrastim dacarbazine doxorubicin hyd... ifosfamide semaxanib conventional su... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer | NCT00436410 | Adrenocortical ... Breast Cancer Colorectal Canc... Gastrointestina... Kidney Cancer Liver Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Sarcoma | colloidal gold-... electron micros... pharmacological... conventional su... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma | NCT00023738 | Sarcoma | filgrastim dacarbazine doxorubicin hyd... ifosfamide semaxanib conventional su... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma | NCT00002995 | Sarcoma | dactinomycin filgrastim sargramostim cyclophosphamid... vincristine sul... radiation thera... | - 49 Years | Children's Oncology Group | |
| Vaccine Therapy and Sargramostim in Treating Patients With Soft Tissue Sarcoma | NCT00027911 | Sarcoma | NY-ESO-1 peptid... sargramostim | 18 Years - | Columbia University | |
| EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer | NCT00087191 | Advanced Adult ... Carcinoma of th... Fallopian Tube ... Gastrointestina... Localized Extra... Localized Gallb... Localized Gastr... Localized Resec... Localized Unres... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Primary Periton... Recurrent Adult... Recurrent Adult... Recurrent Colon... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Small... Recurrent Uteri... Regional Gastro... Small Intestine... Small Intestine... Small Intestine... Stage 0 Non-sma... Stage I Adult S... Stage I Colon C... Stage I Gastric... Stage I Non-sma... Stage I Ovarian... Stage I Ovarian... Stage I Pancrea... Stage I Rectal ... Stage I Uterine... Stage II Adult ... Stage II Colon ... Stage II Gastri... Stage II Non-sm... Stage II Ovaria... Stage II Ovaria... Stage II Pancre... Stage II Rectal... Stage II Uterin... Stage III Adult... Stage III Colon... Stage III Gastr... Stage III Ovari... Stage III Ovari... Stage III Pancr... Stage III Recta... Stage III Uteri... Stage IIIA Non-... Stage IIIB Non-... Stage IV Adult ... Stage IV Colon ... Stage IV Gastri... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Rectal... Stage IV Uterin... Unresectable Ex... Unresectable Ga... | EF5 motexafin lutet... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Sorafenib and Ifosfamide in Treating Patients With High-Grade Soft Tissue Sarcoma or Bone Sarcoma That Can Be Removed by Surgery | NCT00880542 | Sarcoma | sorafenib Ifosfamide | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma | NCT00002995 | Sarcoma | dactinomycin filgrastim sargramostim cyclophosphamid... vincristine sul... radiation thera... | - 49 Years | Children's Oncology Group | |
| Interferon Alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma | NCT00026416 | Sarcoma | recombinant int... thalidomide adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg | NCT00589121 | Lymphedema Musculoskeletal... Radiation Fibro... Radiation Toxic... Sarcoma | Chemotherapy Radiation thera... Surgery | 18 Years - | Radiation Therapy Oncology Group | |
| MRI Sarcoma Non Invasive Thermometry | NCT00093509 | Sarcoma | doxorubicin hyd... ifosfamide and ... hyperthermia tr... radiation thera... | 18 Years - | Duke University | |
| S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor | NCT00068367 | Sarcoma | erlotinib hydro... | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery | NCT00450736 | Childhood Malig... Sarcoma | celecoxib adjuvant therap... radiation thera... | 18 Years - 120 Years | University of Miami | |
| Bevacizumab in Treating Patients With Angiosarcoma | NCT00288015 | Sarcoma | Bevacizumab | 18 Years - | Northwestern University | |
| Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma | NCT00002641 | Endometrial Can... Kidney Cancer Ovarian Cancer Pheochromocytom... Sarcoma | filgrastim doxorubicin hyd... ifosfamide isolated perfus... adjuvant therap... conventional su... radiation thera... | 16 Years - 69 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma | NCT00423618 | Sarcoma | radiotherapy | 16 Years - 120 Years | Sheffield Teaching Hospitals NHS Foundation Trust | |
| Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma | NCT00740597 | Sarcoma | gene expression... polymerase chai... western blottin... neoadjuvant the... therapeutic con... intensity-modul... | 18 Years - | City of Hope Medical Center | |
| EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma | NCT00004261 | Breast Cancer Cervical Cancer Head and Neck C... Prostate Cancer Sarcoma | EF5 flow cytometry fluorescent ant... immunohistochem... biopsy | 18 Years - 120 Years | University Health Network, Toronto | |
| Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma | NCT00061984 | Sarcoma | pegfilgrastim doxorubicin hyd... ifosfamide multimodality t... | 18 Years - 60 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma | NCT00002492 | Sarcoma | cisplatin doxorubicin hyd... isolated limb p... conventional su... brachytherapy radiation thera... | 18 Years - 120 Years | University of Miami | |
| Alanosine in Treating Patients With Cancer | NCT00062283 | Lung Cancer Malignant Mesot... Pancreatic Canc... Sarcoma | L-alanosine | 13 Years - | National Cancer Institute (NCI) | |
| Cryosurgery in Treating Patients With Soft Tissue Sarcoma | NCT00002863 | Sarcoma | chemotherapy conventional su... cryosurgery | - | University of Southern California | |
| Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma | NCT00023738 | Sarcoma | filgrastim dacarbazine doxorubicin hyd... ifosfamide semaxanib conventional su... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Fluorothymidine F-18 PET in Diagnosing Patients With Intermediate or High Grade Soft Tissue Sarcoma | NCT03613259 | Stage II Adult ... Stage IIA Adult... Stage IIB Adult... Stage IIC Adult... Stage III Adult... Stage IV Adult ... | Fluorothymidine... Laboratory Biom... Positron Emissi... | 18 Years - | OHSU Knight Cancer Institute | |
| EF5 to Evaluate Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma or Mouth Cancer | NCT00896961 | Stage I Adult S... Stage I Squamou... Stage II Adult ... Stage II Squamo... Stage III Adult... Stage III Squam... | EF5 diagnostic labo... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma | NCT00003052 | Sarcoma | doxorubicin hyd... etoposide ifosfamide conventional su... hyperthermia tr... radiation thera... | 18 Years - 70 Years | National Cancer Institute (NCI) | |
| EF5 to Evaluate Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma or Mouth Cancer | NCT00896961 | Stage I Adult S... Stage I Squamou... Stage II Adult ... Stage II Squamo... Stage III Adult... Stage III Squam... | EF5 diagnostic labo... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Interferon Alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma | NCT00026416 | Sarcoma | recombinant int... thalidomide adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma | NCT00077285 | Sarcoma | filgrastim carboplatin cyclophosphamid... dexrazoxane hyd... doxorubicin hyd... etoposide ifosfamide irinotecan hydr... vincristine sul... conventional su... radiation thera... | - 50 Years | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma | NCT00003958 | Adult Malignant... Adult Rhabdomyo... Alveolar Childh... Childhood Malig... Embryonal Child... Embryonal-botry... Nonmetastatic C... Previously Untr... Stage I Adult S... Stage II Adult ... Stage III Adult... | dactinomycin vincristine sul... cyclophosphamid... therapeutic con... radiation thera... topotecan hydro... filgrastim sargramostim laboratory biom... | - 49 Years | Children's Oncology Group | |
| Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery | NCT00450736 | Childhood Malig... Sarcoma | celecoxib adjuvant therap... radiation thera... | 18 Years - 120 Years | University of Miami | |
| Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX | NCT00900211 | Sarcoma | microarray anal... molecular diagn... biologic sample... | 16 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
